Stocks and Investing Stocks and Investing
Thu, August 15, 2024

Serge Belanger Reiterated (ARQT) at Strong Buy and Held Target at $18 on, Aug 15th, 2024


Published on 2024-10-28 13:41:34 - WOPRAI, Serge Belanger
  Print publication without navigation


Serge Belanger of Needham, Reiterated "Arcutis Biotherapeutics, Inc." (ARQT) at Strong Buy and Held Target at $18 on, Aug 15th, 2024.

Serge has made no other calls on ARQT in the last 4 months.



There is 1 other peer that has a rating on ARQT. Out of the 1 peers that are also analyzing ARQT, 0 agree with Serge's Rating of Hold.



This is the rating of the analyst that currently disagrees with Serge


  • Uy Ear of "Mizuho" Maintained at Strong Buy with Increased Target to $18 on, Wednesday, May 15th, 2024
Contributing Sources